Pharmaceutical interventions facilitate premedication and prevent opioid-induced constipation and emesis in cancer patients

Supportive Care in Cancer

Volumn 18, Issue 12, 2010, Pages 1531-1538

  Ishihara, Masashi ^a   Iihara, Hirotoshi ^a   Okayasu, Shinji ^a   Yasuda, Koji ^a   Matsuura, Katsuhiko ^a   Suzui, Masumi ^b   Itoh, Yoshinori ^a  

^a GIFU UNIVERSITY HOSPITAL   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Antiemetics; Constipation; Laxatives; Nausea vomiting; Opioid analgesic; Prophylaxis

Indexed keywords

LAXATIVE; MAGNESIUM OXIDE; NARCOTIC ANALGESIC AGENT; PANTETHINE; PICOSULFATE SODIUM; PROCHLORPERAZINE; SENNOSIDE;

ADULT; AGED; ARTICLE; CANCER PAIN; CANCER PATIENT; CONSTIPATION; DRUG EFFICACY; DRUG INFORMATION; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NAUSEA; OPIOID INDUCED EMESIS; PATIENT EDUCATION; PATIENT INFORMATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; ANTIEMETICS; CONSTIPATION; FEMALE; HUMANS; LAXATIVES; MALE; MIDDLE AGED; NAUSEA; NEOPLASMS; PAIN; PREMEDICATION; TREATMENT OUTCOME; VOMITING;

EID: 78349308601     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-009-0775-3     Document Type: Article

References (32)

1. JM Koeller 1990 Understanding cancer pain Am J Hosp Pharm 47 8 Suppl S3 S6 1:STN:280:DyaK3czlvVansg%3D%3D 2202210
2. MZ Cohen MK Easley C Ellis B Hughes K Ownby BG Rashad M Rude E Taft JB Westbrooks 2003 JCAHO. Cancer pain management and the JCAHO's pain standards: an institutional challenge J Pain Symptom Manage 25 519 527 10.1016/S0885-3924(03) 00068-X 12782432 (Pubitemid 36629275)
3. KB Svendsen S Andersen S Arnason S Arnér H Breivik T Heiskanen E Kalso UE Kongsgaard P Sjogren P Strang FW Bach TS Jensen 2005 Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms Eur J Pain 9 195 206 10.1016/j.ejpain.2004.06.001 15737812 (Pubitemid 40311842)
4. SA Schug D Zech S Grond H Jung T Meuser B Stobbe 1992 A long-term survey of morphine in cancer pain patients J Pain Symptom Manage 7 259 266 1:STN:280:DyaK38zisFGhug%3D%3D 10.1016/0885-3924(92)90059-Q 1624812
5. N Cherny C Ripamonti J Pereira C Davis M Fallon H McQuay S Mercadante G Pasternak V Ventafridda Expert Working Group of the European Association of Palliative Care Network 2001 Strategies to manage the adverse effects of oral morphine: An evidence-based report J Clin Oncol 19 2542 2554 1:CAS:528:DC%2BD3MXjvVelu78%3D 11331334
6. E McNicol N Horowicz-Mehler RA Fisk K Bennett M Gialeli-Goudas PW Chew J Lau D Carr 2003 American Pain Society. Management of opioid side effects in cancer-related and chronic noncancer pain: a systematic review J Pain 4 231 256 10.1016/S1526-5900(03)00556-X 14622694 (Pubitemid 36807905)
7. R Fiocchi G Bianchi P Petrillo A Tavani L Manara 1982 Morphine inhibits gastrointestinal transit in the rat primarily by impairing propulsive activity of the small intestine Life Sci 31 2221 2223 1:CAS:528:DyaL3sXktFA%3D 10.1016/0024-3205(82)90123-0 7162339 (Pubitemid 13225530)
8. JF Foss AS Bass LI Goldberg 1993 Dose-related antagonism of the emetic effect of morphine by methylnaltrexone in dogs J Clin Pharmacol 33 747 751 1:CAS:528:DyaK2cXktVSlsrY%3D 8408737
9. MP Davis D Walsh 2000 Treatment of nausea and vomiting in advanced cancer Support Care Cancer 8 444 452 1:STN:280:DC%2BD3MzgtlWqug%3D%3D 10.1007/s005200000151 11094988
10. A Shahbazian A Heinemann H Schmidhammer E Beubler U Holzer-Petsche P Holzer 2002 Involvement of mu- and kappa-, but not delta-, opioid receptors in the peristaltic motor depression caused by endogenous and exogenous opioids in the guinea-pig intestine Br J Pharmacol 135 741 750 1:CAS:528: DC%2BD38XhvVejsbg%3D 10.1038/sj.bjp.0704527 11834622
11. KP Bhargava KS Dixit YK Gupta 1981 Enkephalin receptors in the emetic chemoreceptor trigger zone of the dog Br J Pharmacol 72 471 475 1:CAS:528:DyaL3MXkslens7c%3D 6266566
12. DB Murphy JA Sutton LF Prescott MB Murphy 1997 Opioid-induced delay in gastric emptying: a peripheral mechanism in humans Anesthesiology 87 765 770 1:CAS:528:DyaK2sXntFCjt7g%3D 10.1097/00000542-199710000-00008 9357876 (Pubitemid 27456227)
13. B Estfan T Yavuzsen M Davis 2005 Development of opioid-induced delirium while on olanzapine: a two-case report J Pain Symptom Manage 29 330 332 10.1016/j.jpainsymman.2005.02.004 15857733 (Pubitemid 40602510)
14. W Raffaeli G Marconi G Fanelli S Taddei GB Borghi A Casati 2006 Opioid-related side-effects after intrathecal morphine: a prospective, randomized, double-blind dose-response study Eur J Anaesthesiol 23 605 610 1:CAS:528:DC%2BD28Xnt1WktrY%3D 10.1017/S026502150600038X 16507190
15. JD Gaudreau P Gagnon MA Roy F Harel A Tremblay 2007 Opioid medications and longitudinal risk of delirium in hospitalized cancer patients Cancer 109 2365 2373 1:CAS:528:DC%2BD2sXmvVKjsb0%3D 10.1002/cncr.22665 17469164 (Pubitemid 46801569)
16. TL Skaer 2004 Practice guidelines for transdermal opioids in malignant pain Drugs 64 2629 2638 1:CAS:528:DC%2BD2MXks1WhtA%3D%3D 10.2165/00003495- 200464230-00002 15537367 (Pubitemid 39626368)
17. DB Gordon JL Dahl C Miaskowski B McCarberg KH Todd JA Paice AG Lipman M Bookbinder SH Sanders DC Turk DB Carr 2005 American pain society recommendations for improving the quality of acute and cancer pain management: American Pain Society Quality of Care Task Force Arch Intern Med 165 1574 1580 10.1001/archinte.165.14.1574 16043674 (Pubitemid 41124150)
18. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology v.1. (2009) Adult cancer pain. http://www.nccn.org/professionals/ physician-gls/PDF/pain.pdf
19. PI Williams M Smith 1999 An assessment of prochlorperazine buccal for the prevention of nausea and vomiting during intravenous patient-controlled analgesia with morphine following abdominal hysterectomy Eur J Anaesthesiol 16 638 645 1:CAS:528:DyaK1MXnsVWjur4%3D 10549465
20. RS Lloyd F Costello MJ Eves IG James AJ Miller 1992 The efficacy and tolerability of controlled-release dihydrocodeine tablets and combination dextropropoxyphene/paracetamol tablets in patients with severe osteoarthritis of the hips Curr Med Res Opin 13 37 48 1:STN:280:DyaK3s7gsFKlsA%3D%3D 1468244
21. E Klaschik F Nauck C Ostgathe 2003 Constipation-modern laxative therapy Support Care Cancer 11 679 685 1:STN:280:DC%2BD3srhslGrsQ%3D%3D 10.1007/s00520-003-0525-x 14505158 (Pubitemid 37432623)
22. SD Meed PM Kleinman TG Kantor RH Blum JJ Savarese 1987 Management of cancer pain with oral controlled-release morphine sulfate J Clin Pharmacol 27 155 161 1:STN:280:DyaL1c%2FlvFOnsQ%3D%3D 3680567
23. DA Arce CA Ermocilla H Costa 2002 Evaluation of constipation Am Fam Physician 65 2283 2290 12074527
24. A Trotti AD Colevas A Setser V Rusch D Jaques V Budach C Langer B Murphy R Cumberlin CN Coleman P Rubin 2003 CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 176 181 10.1016/S1053-4296(03)00031-6 12903007 (Pubitemid 36962641)
25. T Hashizume A Kasahara Y Oshima 1972 Biological studies of pantethine. 10. Effects of anesthetics on gastrointestinal-motility promoting effect of pantethine Nippon Yakurigaku Zasshi 68 255 264 1:CAS:528:DyaE2cXksFyhtLk%3D 5066353
26. G Kajiyama T Kawamoto C Fukuhara I Horiuchi M Nakagawa A Miyoshi 1981 The effect of pantethine, a precursor of coenzyme A, on bile acids and lipids in rats fed with a cholesterol diet Hiroshima J Med Sci 30 215 220 1:CAS:528:DyaL38XltFSqtg%3D%3D 7298371
27. P Carrara L Matturri M Galbussera, et al. 1984 Pantethine reduces plasma cholesterol and the severity of arterial lesions in experimental hypercholesterolemic rabbits Atherosclerosis 53 255 264 1:CAS:528: DyaL2MXhtVKjt7w%3D 10.1016/0021-9150(84)90126-6 6442152 (Pubitemid 15194148)
28. G Cighetti M Del Puppo R Paroni E Fiorica M Galli Kienle 1987 Pantethine inhibits cholesterol and fatty acid syntheses and stimulates carbon dioxide formation in isolated rat hepatocytes J Lipid Res 28 152 161 1:CAS:528:DyaL2sXhtlGrtbs%3D 3106549
29. G Cighetti M Del Puppo R Paroni M Galli Kienle 1988 Modulation of HMG-CoA reductase activity by pantetheine/pantethine Biochim Biophys Acta 963 389 393 1:CAS:528:DyaL1MXltlGqtA%3D%3D 3196742
30. V Ventafridda L Saita C Ripamonti F De Conno 1985 WHO guidelines for the use of analgesics in cancer pain Int J Tissue React 7 93 96 1:STN:280: DyaL2M3jtlKksw%3D%3D 2409039
31. J Stjernswärd 1986 Cancer pain relief-an urgent public health problem J Palliat Care 1 29 30 3450813
32. K Hiraga T Mizuguchi F Takeda 1991 The incidence of cancer pain and improvement of pain management in Japan Postgrad Med J 67 Suppl 2 S14 S25 1758814